WallStreetZenWallStreetZen

NASDAQ: SRPT
Sarepta Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SRPT past revenue growth

How has SRPT's revenue growth performed historically?
Company
33.26%
Industry
151.46%
Market
17.61%
SRPT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SRPT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SRPT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SRPT earnings and revenue history

Current Revenue
$1.2B
Current Earnings
-$536.0M
Current Profit Margin
-43.1%

SRPT Return on Equity

Current Company
-69.7%
Current Industry
-63.5%
Current Market
188%
SRPT's Return on Equity (-69.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SRPT announces earnings.

SRPT Return on Assets

Current Company
-17.1%
Current Industry
2.9%
SRPT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SRPT Return on Capital Employed

Current Company
-19.92%
Current Industry
19.5%
SRPT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SRPT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SRPT$1.24B-$461.21M-$535.98M+32.80%N/A
UTHR$2.33B$1.39B$984.80M+7.41%+9.22%
INCY$3.70B$919.43M$597.60M+14.45%+38.71%
TECH$1.14B$372.91M$224.16M+10.93%+17.11%
LEGN$285.14M-$477.87M-$518.25M+42.15%N/A
View Top Biotech Stocks

SRPT earnings dates

Next earnings date
Apr 30, 2024

Sarepta Therapeutics Earnings & Revenue FAQ

What were SRPT's earnings last quarter?

On Invalid Date, Sarepta Therapeutics (NASDAQ: SRPT) reported Q4 2023 earnings per share (EPS) of $0.76, up 161.29% year over year. Total Sarepta Therapeutics earnings for the quarter were $45.66 million. In the same quarter last year, Sarepta Therapeutics's earnings per share (EPS) was -$1.24.

If you're new to stock investing, here's how to buy Sarepta Therapeutics stock.

What was SRPT's earnings growth in the past year?

As of Q2 2024, Sarepta Therapeutics's earnings has grown year over year. Sarepta Therapeutics's earnings in the past year totalled -$535.98 million.

What is SRPT's earnings date?

Sarepta Therapeutics's earnings date is Invalid Date. Add SRPT to your watchlist to be reminded of SRPT's next earnings announcement.

What was SRPT's revenue last quarter?

On Invalid Date, Sarepta Therapeutics (NASDAQ: SRPT) reported Q4 2023 revenue of $396.78 million up 53.54% year over year. In the same quarter last year, Sarepta Therapeutics's revenue was $258.43 million.

What was SRPT's revenue growth in the past year?

As of Q2 2024, Sarepta Therapeutics's revenue has grown 33.26% year over year. This is 118.2 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Sarepta Therapeutics's revenue in the past year totalled $1.24 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.